Daniel Spratt

3.0k total citations
50 papers, 2.2k citations indexed

About

Daniel Spratt is a scholar working on Endocrinology, Diabetes and Metabolism, Reproductive Medicine and Pulmonary and Respiratory Medicine. According to data from OpenAlex, Daniel Spratt has authored 50 papers receiving a total of 2.2k indexed citations (citations by other indexed papers that have themselves been cited), including 23 papers in Endocrinology, Diabetes and Metabolism, 16 papers in Reproductive Medicine and 8 papers in Pulmonary and Respiratory Medicine. Recurrent topics in Daniel Spratt's work include Ovarian function and disorders (11 papers), Hypothalamic control of reproductive hormones (11 papers) and Hormonal and reproductive studies (10 papers). Daniel Spratt is often cited by papers focused on Ovarian function and disorders (11 papers), Hypothalamic control of reproductive hormones (11 papers) and Hormonal and reproductive studies (10 papers). Daniel Spratt collaborates with scholars based in United States, United Kingdom and Türkiye. Daniel Spratt's co-authors include William F. Crowley, Marco Filicori, Nanette Santoro, Louis O’Dea, W F Crowley, Christopher Longcope, James P. Butler, Thomas M. Badger, Joel S. Finkelstein and Jonathan Himmelfarb and has published in prestigious journals such as Journal of Clinical Investigation, Annals of Internal Medicine and The Journal of Clinical Endocrinology & Metabolism.

In The Last Decade

Daniel Spratt

49 papers receiving 2.1k citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name	h						Papers	Cites
Daniel Spratt United States	25	878	872	453	271	268	50	2.2k
Massimo Giusti Italy	29	299 0.3×	1.7k 2.0×	307 0.7×	157 0.6×	199 0.7×	194	3.1k
Judith L. Luborsky United States	25	1.1k 1.3×	767 0.9×	396 0.9×	641 2.4×	456 1.7×	53	2.6k
R. G. Hoskins	1	339 0.4×	1.3k 1.4×	783 1.7×	220 0.8×	613 2.3×	2	3.0k
Jacky M. Burrin United Kingdom	30	448 0.5×	992 1.1×	580 1.3×	154 0.6×	426 1.6×	93	2.6k
Daniel L. Metzger Canada	29	321 0.4×	736 0.8×	649 1.4×	252 0.9×	621 2.3×	82	2.5k
Vincenzo Rochira Italy	37	982 1.1×	1.9k 2.2×	937 2.1×	351 1.3×	1.2k 4.5×	150	3.9k
Theresa M. Siler-Khodr United States	27	684 0.8×	423 0.5×	264 0.6×	485 1.8×	210 0.8×	82	2.6k
Allan R. Glass United States	25	588 0.7×	986 1.1×	390 0.9×	295 1.1×	208 0.8×	60	2.0k
Jamshid Alaghband‐Zadeh United Kingdom	24	236 0.3×	497 0.6×	359 0.8×	232 0.9×	168 0.6×	73	1.7k
J. Duncan Phillips United States	21	290 0.3×	1.8k 2.0×	756 1.7×	117 0.4×	313 1.2×	41	3.8k

Countries citing papers authored by Daniel Spratt

Since Specialization

Citations

This map shows the geographic impact of Daniel Spratt's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Daniel Spratt with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Daniel Spratt more than expected).

Fields of papers citing papers by Daniel Spratt

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Daniel Spratt. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Daniel Spratt. The network helps show where Daniel Spratt may publish in the future.

Co-authorship network of co-authors of Daniel Spratt

This figure shows the co-authorship network connecting the top 25 collaborators of Daniel Spratt. A scholar is included among the top collaborators of Daniel Spratt based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Daniel Spratt. Daniel Spratt is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

Spratt, Daniel, Tanya B. Dorff, Rana R. McKay, et al.. (2024). Evaluating relugolix for the treatment of prostate cancer in real-world settings of care: the OPTYX study protocol. Future Oncology. 20(12). 727–738. 3 indexed citations

Reardon, Mark, B. Bibby, Niluja Thiruthaneeswaran, et al.. (2024). Hypoxia-Associated Gene Signatures Are Not Prognostic in High-Risk Localized Prostate Cancers Undergoing Androgen Deprivation Therapy With Radiation Therapy. International Journal of Radiation Oncology*Biology*Physics. 121(3). 752–760.

Craig, Wendy Y., et al.. (2020). Efficacy of Sex Steroid Therapy Without Progestin or GnRH Agonist for Gonadal Suppression in Adult Transgender Patients. The Journal of Clinical Endocrinology & Metabolism. 106(3). e1290–e1300. 17 indexed citations

Spratt, Daniel, Clara Savage, Wendy Y. Craig, et al.. (2017). Subcutaneous Injection of Testosterone Is an Effective and Preferred Alternative to Intramuscular Injection: Demonstration in Female-to-Male Transgender Patients. The Journal of Clinical Endocrinology & Metabolism. 102(7). 2349–2355. 61 indexed citations

Pulvino, John, et al.. (2015). Gonadotropin-Releasing Hormone Agonist Use to Guide Diagnosis and Treatment of Autoimmune Progesterone Dermatitis. Obstetrics and Gynecology. 125(5). 1114–1116. 7 indexed citations

Spratt, Daniel, Robert S. Kramer, Jeremy R. Morton, et al.. (2008). Characterization of a prospective human model for study of the reproductive hormone responses to major illness. American Journal of Physiology-Endocrinology and Metabolism. 295(1). E63–E69. 14 indexed citations

Spratt, Daniel, Robert S. Kramer, F. L. Lucas, et al.. (2007). Physiological effects of nonthyroidal illness syndrome in patients after cardiac surgery. American Journal of Physiology-Endocrinology and Metabolism. 293(1). E310–E315. 18 indexed citations

Spratt, Daniel, et al.. (2006). Increases in serum estrogen levels during major illness are caused by increased peripheral aromatization. American Journal of Physiology-Endocrinology and Metabolism. 291(3). E631–E638. 69 indexed citations

Simmons, Edith, Jonathan Himmelfarb, Mehmet Tuğrul Sezer, et al.. (2004). Plasma cytokine levels predict mortality in patients with acute renal failure. Kidney International. 65(4). 1357–1365. 338 indexed citations

10.

Spratt, Daniel. (2001). Altered gonadal steroidogenesis in critical illness: is treatment with anabolic steroids indicated?. Best Practice & Research Clinical Endocrinology & Metabolism. 15(4). 479–494. 44 indexed citations

11.

Walter, Yulia H., et al.. (2000). Mealtime glucose regulation by nateglinide in type-2 diabetes mellitus. European Journal of Clinical Pharmacology. 56(2). 129–133. 17 indexed citations

12.

Himmelfarb, Jonathan, et al.. (1994). Kt/V, Nutritional Parameters, Serum Cortisol, and Insulin Growth Factor-1 Levels and Patient Outcome in Hemodialysis. American Journal of Kidney Diseases. 24(3). 473–479. 26 indexed citations

13.

Spratt, Daniel. (1993). Differential changes in serum concentrations of androgens and estrogens (in relation with cortisol) in postmenopausal women with acute illness. The Journal of Clinical Endocrinology & Metabolism. 76(6). 1542–1547. 13 indexed citations

14.

Finkelstein, Joel S., Daniel Spratt, Louis O’Dea, et al.. (1989). Pulsatile Gonadotropin Secretion after Discontinuation of Long Term Gonadotropin-Releasing Hormone (GnRH) Administration in a Subset of GnRH-Deficient Men*. The Journal of Clinical Endocrinology & Metabolism. 69(2). 377–385. 19 indexed citations

15.

Lowe, William L., Charles T. Roberts, Derek LeRoith, et al.. (1989). Insulin-Like Growth Factor-II in Nonislet Cell Tumors Associated with Hypoglycemia: Increased Levels of Messenger Ribonucleic Acid*. The Journal of Clinical Endocrinology & Metabolism. 69(6). 1153–1159. 49 indexed citations

16.

Finkelstein, Joel S., Thomas M. Badger, Louis O’Dea, Daniel Spratt, & W F Crowley. (1988). Effects of decreasing the frequency of gonadotropin-releasing hormone stimulation on gonadotropin secretion in gonadotropin-releasing hormone-deficient men and perifused rat pituitary cells.. Journal of Clinical Investigation. 81(6). 1725–1733. 28 indexed citations

17.

Crowley, William F., et al.. (1987). Approaches to the Study of GnRH in Humans: Implications for Design of Effective Therapies^a. Annals of the New York Academy of Sciences. 519(1). 269–286. 5 indexed citations

18.

Spratt, Daniel, et al.. (1986). Long-Term Administration of Gonadotropin-Releasing Hormone in Men with Idiopathic Hypogonadotropic Hypogonadism. Annals of Internal Medicine. 105(6). 848–855. 44 indexed citations

19.

Spratt, Daniel, Joel S. Finkelstein, Thomas M. Badger, James P. Butler, & William F. Crowley. (1986). Bio- and Immunoactive Luteinizing Hormone Responses to Low Doses of Gonadotropin-Releasing Hormone (GnRH): Dose-Response Curves in GnRH-Deficient Men*. The Journal of Clinical Endocrinology & Metabolism. 63(1). 143–150. 36 indexed citations

20.

Pont, Allan & Daniel Spratt. (1983). Hyperthyroxinemia in patients with acute psychiatric disorders. The American Journal of Medicine. 75(5). A49–A49. 5 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact